Zolbetuximab — now with the brand name Vyloy — is a monoclonal antibody to treat patients with advanced gastric and ...

Chronic and acute graft-versus-host disease are managed differently, affect different organs, and impact patients in ...

The CDC’s Timothy M. Uyeki, M.D, however, cautioned that if the virus changes, and especially if it begins to infect pigs, ...

Only 15% of those who start a glucagon-like peptide 1 (GLP-1) for weight loss are still taking it two years according to ...

Kristen Whelchel, Pharm.D., CSP, Research and Patient Care Improvement Pharmacist with Vanderbilt Specialty Pharmacy's Department of Health Outcomes and Research, explains how technology identifies at ...

The FDA has already made more than a dozen cancer drug approval decisions this year and more expected in the next several ...

Statins have had an evolving role in the management of cardiovascular risk in people living with HIV, explained Michelle Cespedes, M.D., M.S., professor of medicine, Icahn School of Medicine at Mount ...

Research might produce treatments of involving transplants with a few, selected types of bacteria tailored to an individual's ...

One of two new studies found most patients doing well six years after treatment. Another study found blood cancers in 17% of ...

After expansion of Medicaid, there was a significant decrease in the low-income population with no healthcare coverage.

Even people living with HIV who have undetectable viral loads experience elevated inflammation levels, explained Michelle Cespedes, M.D., M.S, of Mount Sinai Health System.

Building relationships with state and local officials and repairing the tattered primary care system in the U.S. were some of ...